Join this session to review the mechanism of action, Phase 3 study data, and latest interim long-term data for cardiac myosin inhibition in adults with obstructive HCM. Additionally, this session will describe the steps of patient identification and appropriate treatment and monitoring using an illustrative patient case.
Join us for our industry expert panel, Helping Hearts: Supporting Equitable Care for Women with Heart Failure, to hear insights from cardiologists and heart failure community members on how to address health disparities and deliver tailored, equitable care for women living with heart failure.
Transthyretin amyloid cardiomyopathy (or ATTR-CM) is a serious underrecognized and underdiagnosed disease that frequently presents as heart failure. Join us to help raise awareness of the signs and symptoms of ATTR-CM, and the role of cardiac health professionals in suspecting, diagnosing, and confirming ATTR-CM.
Join us for a symposium on current clinical practice gaps related to heart failure designed to encourage the exchange of ideas between leaders in the field and attendees.
Join us for a live CME discussion with Drs Rajan Saggar and Victor Tapson focusing on current and emerging treatment options for patients with pulmonary arterial hypertension. The discussion will be followed by a live Q&A in which you will be welcomed to ask questions of our experts.